Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager’s wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, and other severe neurological diseases.
Contact:
Voyager Therapeutics
75 Sidney St.
Cambridge, MA 02139
info@voyagertherapeutics.com
857-259-5340
Location: United States, Massachusetts, Cambridge
Employees: 201-500
Total raised: $105M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | PFM Health... | pfmhealths... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.04.2015 | Series B | $60M | - |
| 12.02.2014 | Series A | $45M | - |
Mentions in press and media 20
| Date | Title | Description | Source |
| 13.03.2024 | Voyager Therapeutics Announces Appointment of Toby Ferguson ... | - | globenewsw... |
| 11.12.2021 | Voyager Therapeutics : Corporate Presentation | UNLOCKING THE POTENTIAL OF AAV GENE THERAPY Corporate Presentation | December 2021 © Voyager Therape... | marketscre... |
| 06.10.2021 | Voyager Therapeutics’ strategy shift to gene therapy tech le... | With its lead gene therapy programs stalled by a series of setbacks, Voyager Therapeutics has been t... | medcitynew... |
| 04.08.2020 | AbbVie shrugs off $134M cash deals, quitting a neuro R&a... | It’s the end of the road for Voyager Therapeutics’ collaboration with AbbVie on tau and al... | endpts.com... |
| 17.06.2019 | Sanofi, Voyager Therapeutics rejig gene therapy partnership | Shares of Voyager were up 14 percent on the Nasdaq late Monday morning following the news. Shares of... | medcitynew... |
| 27.03.2019 | Prevail Therapeutics raises $50M for gene therapy in Parkins... | According to its website, the company’s focus is on developing adeno-associated viral vector-based g... | medcitynew... |
| 11.06.2018 | Pharma giants like Novartis, Pfizer, and Sanofi are getting ... | AP Photo/Eric Risberg In this photo taken Monday, Nov. 13, 2017, nurse practitioner Jacqueline Madde... | businessin... |
| 06.09.2017 | News of Note—Sarepta, Verastem and Voyager clock data win, s... | > Sarepta Therapeutics saw its shares jump 13% in early morning trading on new phase 1/2 data fro... | fiercebiot... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 11.11.2015 | $172M in IPOs from Wave Life Sciences, Voyager Therapeutics | Wave, a Harvard spinout, is using synthetic chemistry to develop a pipeline of nucleic acid therapeu... | medcitynew... |
Show more